|
KIAA0240 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.137000E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.919600E-01 |
| Normal-vs-Stage2 |
4.156600E-01 |
| Normal-vs-Stage3 |
1.677950E-02 |
| Normal-vs-Stage4 |
6.27100000000214E-05 |
| Stage1-vs-Stage2 |
1.654030E-01 |
| Stage1-vs-Stage3 |
1.664950E-03 |
| Stage1-vs-Stage4 |
2.5365000000388E-07 |
| Stage2-vs-Stage3 |
3.858200E-01 |
| Stage2-vs-Stage4 |
4.732200E-02 |
| Stage3-vs-Stage4 |
1.025170E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.982810E-01 |
| Normal-vs-AfricanAmerican |
4.104400E-01 |
| Normal-vs-Asian |
3.183000E-01 |
| Caucasian-vs-AfricanAmerican |
7.844800E-01 |
| Caucasian-vs-Asian |
6.759600E-02 |
| AfricanAmerican-vs-Asian |
1.926420E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.276590E-01 |
| Normal-vs-Female |
6.726800E-01 |
| Male-vs-Female |
2.484400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.217600E-01 |
| Normal-vs-Age(41-60Yrs) |
6.865000E-01 |
| Normal-vs-Age(61-80Yrs) |
2.112000E-02 |
| Normal-vs-Age(81-100Yrs) |
4.320500E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.255400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.771400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.958200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.859500E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.582100E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.627400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
7.036100E-03 |
| Normal-vs-Grade 2 |
3.842200E-01 |
| Normal-vs-Grade 3 |
9.234400E-02 |
| Normal-vs-Grade 4 |
2.39810000002283E-06 |
| Grade 1-vs-Grade 2 |
1.065950E-01 |
| Grade 1-vs-Grade 3 |
1.006040E-02 |
| Grade 1-vs-Grade 4 |
1.80921999999306E-05 |
| Grade 2-vs-Grade 3 |
7.619100E-03 |
| Grade 2-vs-Grade 4 |
2.20350000024183E-07 |
| Grade 3-vs-Grade 4 |
1.679740E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.370300E-02 |
| Normal-vs-ccB subtype |
3.559900E-02 |
| ccA subtype-vs-ccB subtype |
1.93131999999263E-05 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.971800E-01 |
| Normal-vs-N1 |
1.735620E-01 |
| N0-vs-N1 |
2.012400E-01 |
|
|
